Barcelona, Spain 
Blood Brain Barrier-Targeted Therapeutics
Blood-brain barrier(BBB) is one of the major challenges in treating neurological disorders. New strategies such as carrier-mediated nanoparticles, liposomes, exosomes, and receptor-mediated transport systems, including peptide and antibody-based targeting, are being developed to overcome the challenges of the blood–brain barrier and enhance drug access to the central nervous system (CNS) effectively. Non-invasive approaches such as intranasal drug delivery are emerging as promising alternatives to bypass the blood–brain barrier. These strategies hold significant potential in the treatment of neurodegenerative diseases, including Alzheimer’s and Parkinson’s, as well as brain tumors, epilepsy, and central nervous system (CNS) infections. BBB-targeted drug delivery advances are essential for precision neuro-medicine, as they enable more effective treatment of central nervous system (CNS) disorders and hold the potential to significantly improve patient outcomes.
Translational Approaches in Cancer Drug Delivery and Immunotherapy
Drug delivery plays a pivotal role in advancing cancer treatment and immune-based therapies. This track focuses on innovative delivery platforms such as nanoparticles, liposomes, micelles, hydrogels, and antibody-drug conjugates that improve tumor targeting, therapeutic efficacy, drug stability, and reduce toxicity, safety profiles. It also highlights drug delivery with immunotherapy approaches, including immune checkpoint inhibitors, cancer vaccines, monoclonal antibodies, and CAR-T cell therapies to enhance precision, reduce systemic toxicity, and overcome resistance mechanisms. Applications range from solid tumors to hematological cancers, focusing on precision medicine, personalized therapies, and overcoming resistance mechanisms to bring cutting-edge science closer to patient care.
Peptide/Protein Formulations and Delivery Technologies
Peptides and proteins have emerged as powerful bio-therapeutics due to their high specificity and potent activity, yet their clinical use is often limited by instability, poor bioavailability, and delivery challenges. This track explores innovative formulation strategies and delivery systems, including nanoparticles, liposomes, hydrogels, microneedles, and implantable devices designed to protect, stabilize, and enhance the targeted delivery of peptide- and protein-based drugs. Discussions will cover oral, injectable, transdermal, and novel non-invasive approaches, as well as advances in bio-conjugates, sustained-release systems, and bio-responsive carriers, paving the way for next-generation biopharmaceutical therapies.
Nanotechnology for Therapeutic Delivery
Nanotechnology plays a crucial role in drug delivery, enabling targeted, controlled transport of medications to specific sites and enhancing efficacy. Nano carriers include polymeric nanoparticles, mesoporous silica nanoparticles, dendrimers, nanocrystals, Nano gels, Nano capsules, and carbon nanotubes, providing control over drug release with reduced toxicity and minimal side effects. Nanoparticles enhance the solubility and absorption of poorly soluble drugs, increasing their bioavailability in the body. Applied in areas such as oncology, neurological disorders, gene therapy, diabetes, infectious diseases, and regenerative medicine. With their ability to cross biological barriers like the blood-brain barrier and protect sensitive drugs, nanostructures represent a cornerstone of next-generation personalized medicine.
AI and Digital Transformation in Pharmaceutical R&D
Artificial intelligence and digital technologies revolutionize pharmaceutical research and development, enabling effective drug discovery and delivery. AI is redefining healthcare through precision medicine and next-generation innovations. Digital platforms enhance clinical trial design, patient monitoring. Machine learning models to optimize excipients, dosage forms, and release profiles. AI models support pharmacokinetics, dose optimization, Smart devices & wearables, quality control, and real-time monitoring. AI-guided dosing algorithms, linked to drug delivery monitoring, support nanocarriers and biologics formulations.
Next-Generation 3D Printed Dosage Forms
3D printing is revolutionizing pharmaceutical sciences by enabling to develop personalized, precise, and on-demand drug formulations. This cutting-edge technology allows the creation of tailored dosage forms with controlled release profiles, complex geometries, and patient-specific combinations. 3D printing offers a paradigm shift in drug development, paving the way for next-generation precision medicine. Combines multiple medications into one unit for a personalized patient. This technology provides Novel Dosage Forms, Controlled drug release pharmacokinetics for targeted therapies, and Decentralized production for hospitals and pharmacies. 3D printing also integrates with nanotechnology, biologics, and smart drug delivery systems.
Eco-Friendly Pharmaceutical Manufacturing
Pharmaceutical Manufacturing focuses on developing eco-friendly and resource-efficient processes in the production of medicines. It emphasizes reducing waste, minimizing energy consumption, and using safer chemicals, all while maintaining high-quality pharmaceutical standards. By integrating sustainability into manufacturing, the pharmaceutical industry can lower its environmental footprint, promote patient and environmental safety, and contribute to a healthier planet.
Smart Biomaterials and Polymer-Based Therapeutics
Smart Biomaterials and Polymer-Based drug delivery are advanced materials engineered to respond to specific biological or environmental triggers such as pH, temperature, and light, enabling precise drug delivery and controlled therapeutic effects. These polymers can enhance drug stability, target specific tissues, and improve patient outcomes by releasing medications in a controlled, responsive manner. Their versatility and biocompatibility support tissue engineering and implantable devices, making them a cornerstone of next-generation therapies and personalized medicine. Biomaterials focus on biodegradable, responsive, and self-healing materials that improve precision and minimize side effects.
Cutting-Edge Vaccine Formulations and Delivery
Vaccine Delivery Technologies focus on innovative methods to safely and effectively deliver vaccines to the body. These technologies aim to improve immune response, enhance stability, and simplify administration, ranging from traditional injections to novel approaches like microneedle patches, nanoparticles, and oral formulations. By optimizing how vaccines are delivered, they increase accessibility, efficacy, and patient compliance. Advances aim to enhance antigen presentation, prolong immune response, and large-scale distribution, making vaccination more effective and accessible over diverse populations.
Transdermal and Intradermal Delivery Innovations
Advanced technologies, including microneedles, patches, and nanoparticle-based formulations, enhance drug penetration, improve bioavailability, and reduce discomfort compared to conventional injections. These innovations enable precise, minimally invasive, and patient-friendly treatments. Transdermal and intradermal systems offer non-invasive alternatives for drug administration through the skin, improving patient compliance and avoiding first-pass metabolism. Transdermal patches, microneedles, and nano-formulated gels provide steady drug release over time, while intradermal injections enable localized treatment and efficient vaccine delivery. Advances in skin permeation enhancers and polymeric carriers have expanded the range of drugs deliverable via this route. These systems are particularly beneficial for hormonal therapies, pain management, and immunizations, offering a convenient and effective approach to systemic and localized treatments.
Advanced Carriers: Liposomes, Microspheres, and Hydrogels
Liposomes, Microspheres, and Hydrogels are innovative drug delivery systems designed to improve therapeutic efficacy and targeting, drug encapsulation, protection, and controlled release. Liposomes encapsulate drugs within lipid bilayers for enhanced bioavailability, and microspheres allow controlled and sustained release of small molecules and biologics. Hydrogels with their high water content and tunable properties provide responsive, biocompatible matrices for localized delivery, wound healing, and ophthalmology. Together, these carriers enable in delivery of proteins, vaccines, and genetic material safely in precise, efficient, and patient-friendly treatments.
Patient-Centric and Precision Medicine Drug Development
Invasive and Precision-Guided Delivery Techniques involve targeted administration of therapeutics directly to specific tissues or organs, often using catheters, micro-needles, or image-guided systems. By minimizing systemic exposure, they enhance treatment efficacy, reduce side effects, and enable highly precise interventions for complex diseases. Personalized and precision medicine tailors treatments to an individual’s genetic, molecular, and clinical profile and lifestyle. By considering patient-specific factors, it improves therapeutic outcomes, minimizes adverse effects, and drives the next generation of targeted, data-driven healthcare. Technologies such as diagnostics, pharmacogenomics, and individualized drug dosing platforms are considered. Customized formulations, particularly in oncology and rare diseases, are enhancing therapeutic efficacy and minimizing adverse effects. Digital tools and AI are also supporting personalization.
Ocular Pharmacology and Drug Transport
Delivering drugs to the ophthalmic area is challenging due to protective barriers and drainage mechanisms. Advanced delivery systems, including eye drops, gels, implants, nanoparticles, ocular inserts, iontophoresis, and in situ forming systems, are designed to enhance drug bioavailability, prolong retention time, and reduce systemic side effects, ensuring safe and effective treatment for conditions like glaucoma, retinal disorders, infections, macular degeneration, and post-surgical inflammation. Ophthalmic therapies ensures sterility, biocompatibility, and sustained release.
Aerosol and Nasal Drug Delivery Systems
Aerosol and Nasal Drug Delivery Systems, including nebulizers, sprays, and inhalers, offer rapid onset of action, systemic absorption, enhanced bioavailability, and improved patient compliance. They are widely used for treating respiratory diseases, vaccines, and systemic therapies through mucosal absorption. Nasal sprays are often used to deliver drugs to the brain because they can bypass the blood-brain barrier. Improvements in particle design, delivery devices, and mucoadhesive formulations are helping drugs reach the target site more effectively, remain stable, and be better absorbed.
Trials, Outcomes, and Case Insights in Drug Delivery
Clinical Trials & Case Studies in Drug Delivery evaluate the safety, efficacy, and performance of new drug delivery systems in real-world and controlled settings. Clinical trials provide evidence-based data on pharmacokinetics, therapeutic outcomes, and potential side effects, while case studies highlight specific patient experiences and practical applications. Case studies highlight successes, failures, and learnings from novel delivery technologies across different therapeutic areas. Together, they guide the development of safer, more effective, and patient-centric drug delivery solutions. Data from trials help to form regulatory strategies, market adoption, and post-marketing surveillance. Emphasis is placed on trial design, endpoints, patient recruitment, and compliance monitoring. Real-world evidence supports claims of therapeutic advantage, guiding innovation and clinical practice. Sharing practical insights accelerates the development of more effective delivery systems.
Compliance, Safety, and Quality in Pharmaceuticals
Regulatory Affairs and Quality Assurance ensure that pharmaceutical products comply with all legal, safety, and quality standards throughout development, manufacturing, and distribution. Regulatory affairs focus on obtaining approvals from authorities and maintaining compliance, while quality assurance guarantees consistent product quality, safety, and efficacy. Together, they uphold patient safety, efficacy, and trust in healthcare products. Topics related to Good Manufacturing Practices (GMP), stability testing, bioequivalence, and document submission to global regulatory agencies like FDA, EMA, and ICH. Effective regulatory planning accelerates approvals and minimizes development risks.
Pharmaceutical Preformulation Studies
Preformulation Studies are the initial phase in drug development focused on understanding the physical, chemical, and mechanical properties of a drug substance. These studies evaluate solubility, stability, compatibility, polymorphism, and bioavailability to guide formulation design, optimize drug delivery, and ensure consistent efficacy and safety in the final pharmaceutical product. Preformulation helps identify potential challenges such as degradation or poor absorption, enabling developers to design robust, scalable, and regulatory-compliant formulations from the outset. These studies guide to selection of excipients, dosage forms, and different manufacturing methods.
Clinical Pharmacokinetics and Pharmacodynamics
Knowledge of pharmacokinetics (PK) and pharmacodynamics (PD) is essential for designing safe and effective drug therapies. PK describes how the drug is absorbed, distributed, metabolized, and excreted from the body, while PD focuses on the drug’s biological effects and therapeutic response. Modeling tools and Regulatory strategies help predict human response, optimize dosing, and support regulatory submissions. Integrating PK/PD data with formulation and delivery system design ensures improved efficacy, reduced toxicity, and successful translations. Personalized medicine increasingly relies on PK/PD insights for tailored therapies.
Novel Strategies in Drug Formulation
Innovations in Drug Formulation focus on developing advanced delivery systems and novel dosage forms to enhance therapeutic efficacy, safety, and patient compliance to transform the pharmaceutical industry. These include sustained-release systems, nanocarriers, targeted and responsive formulations, enhanced solubility techniques, and patient-friendly designs that optimize drug stability, bioavailability, and clinical outcomes. Reformulating existing drugs is also opening new opportunities for lifecycle management and improving cost-efficiency.
Smart Oral Drug Delivery Platforms
Oral Drug Delivery refers to advanced systems designed to release drugs in a controlled, targeted, and responsive manner within the gastrointestinal tract. These technologies include pH-sensitive coatings, nanocarriers, and time-release formulations that enhance drug stability, improve bioavailability, especially for poorly water-soluble drugs, and optimize therapeutic outcomes, offering patient-friendly and effective treatment options. Advances in taste masking, pediatric formulations, and fixed-dose combinations are being made to improve patient adherence. Innovations focus on gastro-retentive systems and tablets with sensors. Oral delivery systems are central to improving outcomes, mainly in chronic disease management.